Literature DB >> 28992617

Iodine Promotes Tumorigenesis of Thyroid Cancer by Suppressing Mir-422a and Up-Regulating MAPK1.

Junyi Wang, Haiou Yang, Yiran Si, Dongzhi Hu, Yang Yu, Yan Zhang, Ming Gao, Haiyang Zhang.   

Abstract

BACKGROUND/AIMS: Iodine may trigger tumorigenesis and development of thyroid carcinoma, but the mechanisms involved remained elusive. MicroRNA (MiRNAs) are known to be involved in each stage of cancer development; however, the role of miRNAs in iodine-induced tumorigenesis of thyroid carcinoma remained unknown. In this study, we aimed at investigating miRNA related signaling pathway in thyroid cancer cells.
METHODS: Levels of miRNAs and mRNAs were determined using RT-qPCR and proteins were quantified by western blotting. Cell migration and proliferation were checked using Transwell assay and CCK8 assay respectively. Tumor xenografts in nude mice were established by subcutaneous injection of cancer cells.
RESULTS: Mitogen activated protein kinase 1 (MAPK1) was significantly up-regulated, while miR-422a was down-regulated in thyroid cancer cells cultured with high iodine; miR-422a directly bound to the 3'UTR of MAPK1 mRNA. Moreover, miR-422a negatively regulated MAPK1 expression, and down-regulated miR-422a promoted proliferation and migration of TPC-1 cells. In vivo studies also confirmed that iodine promoted tumor growth by suppressing miR-422a and up-regulating MAPK1.
CONCLUSIONS: Our study illustrates a new pathway comprising iodine, miRNA and MAPK1, and defines a novel mechanism in thyroid cancer.
© 2017 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Iodine; MAPK1; Mir-422a; Thyroid carcinoma; Tumor growth

Mesh:

Substances:

Year:  2017        PMID: 28992617     DOI: 10.1159/000481844

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  13 in total

1.  Clinical roles of miR-136-5p and its target metadherin in thyroid carcinoma.

Authors:  Rui-Zhi Gao; Qiao Que; Peng Lin; Yu-Yan Pang; Hua-Yu Wu; Xiao-Jiao Li; Gang Chen; Yun He; Hong Yang
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

Review 2.  Iodine, Seaweed, and the Thyroid.

Authors:  Peter P A Smyth
Journal:  Eur Thyroid J       Date:  2021-01-27

3.  Long Noncoding RNA CCDC26 Promotes Thyroid Cancer Malignant Progression via miR-422a/EZH2/Sirt6 Axis.

Authors:  Xiao Ma; Yanyan Li; Yuntao Song; Guohui Xu
Journal:  Onco Targets Ther       Date:  2021-05-11       Impact factor: 4.147

4.  A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.

Authors:  Jiajia Feng; Qinyi Zhou; Hongliang Yi; Shiyin Ma; Dawei Li; Yanan Xu; Jiadong Wang; Shankai Yin
Journal:  Cell Death Dis       Date:  2019-06-03       Impact factor: 8.469

5.  MicroRNA-675 directly targets MAPK1 to suppress the oncogenicity of papillary thyroid cancer and is sponged by long non-coding RNA RMRP.

Authors:  Junyi Wang; Tiantian Xiao; Ming Zhao
Journal:  Onco Targets Ther       Date:  2019-09-06       Impact factor: 4.147

6.  Low urinary iodine is a protective factor of central lymph node metastasis in papillary thyroid cancer: a cross-sectional study.

Authors:  Ziyang Zeng; Kang Li; Xianze Wang; Siwen Ouyang; Zimu Zhang; Zhen Liu; Juan Sun; Xin Ye; Weiming Kang; Jianchun Yu
Journal:  World J Surg Oncol       Date:  2021-07-12       Impact factor: 2.754

7.  Downregulation of miR‑486‑5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing.

Authors:  Dong-Yue Wen; Deng-Hua Pan; Peng Lin; Qiu-Yan Mo; Yun-Peng Wei; Yi-Huan Luo; Gang Chen; Yun He; Jun-Qiang Chen; Hong Yang
Journal:  Mol Med Rep       Date:  2018-07-03       Impact factor: 2.952

8.  Association between excessive chronic iodine exposure and the occurrence of papillary thyroid carcinoma.

Authors:  Fengyan Huang; Wei Cong; Juan Xiao; Yong Zhou; Maosong Gong; Jingfu Sun; Liqun Shan; Qiang Xiao; Lihua Wang; Jianing Liu; Zhigang Yu; Hongying Jia
Journal:  Oncol Lett       Date:  2020-09-03       Impact factor: 2.967

9.  Circ_0058124 Upregulates MAPK1 Expression to Promote Proliferation, Metastasis and Metabolic Abilities in Thyroid Cancer Through Sponging miR-940.

Authors:  Dezhong Sun; Li Chen; Huaiqing Lv; Yongli Gao; Xuelai Liu; Xiaoyan Zhang
Journal:  Onco Targets Ther       Date:  2020-02-19       Impact factor: 4.147

10.  Prognostic Value and Significant Pathway Exploration Associated with TOP2A Involved in Papillary Thyroid Cancer.

Authors:  Mou-Chun Gong; Wei-Qing Chen; Zhao-Qing Jin; Jia Lyu; Li-Hao Meng; Hai-Yan Wu; Fei-Hua Chen
Journal:  Int J Gen Med       Date:  2021-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.